Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.
about
PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerExpression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosisDeletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistanceIntegrated physiology and systems biology of PPARαPredictive screening for regulators of conserved functional gene modules (gene batteries) in mammals.Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoformsIs the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?Role of Transcription Factors in Steatohepatitis and Hypertension after Ethanol: The Epicenter of MetabolismEnergy metabolism in the liverHepatic circadian-clock system altered by insulin resistance, diabetes and insulin sensitizer in miceExposure to bisphenol-A during pregnancy partially mimics the effects of a high-fat diet altering glucose homeostasis and gene expression in adult male miceGlial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expressionRegressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat DietSevere Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein ReceptorPeroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in miceA model for obesity and gigantism due to disruption of the Ankrd26 geneThe obesity and fatty liver are reduced by plant-derived Pediococcus pentosaceus LP28 in high fat diet-induced obese miceMolecular mediators of hepatic steatosis and liver injuryPPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.Role of nuclear receptor SHP in metabolism and cancer.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet.Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid compositionGenome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.All-trans-retinoic acid ameliorates hepatic steatosis in mice by a novel transcriptional cascade.HVC1 ameliorates hyperlipidemia and inflammation in LDLR-/- mice.Hepatocyte nuclear factor 4alpha coordinates a transcription factor network regulating hepatic fatty acid metabolism.Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice.Disruption of inducible 6-phosphofructo-2-kinase ameliorates diet-induced adiposity but exacerbates systemic insulin resistance and adipose tissue inflammatory response.Central nervous system melanocortin-3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle.Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice.Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator.Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liverHuman ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early InterventionMitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in miceSteatosis and steatohepatitis: complex disorders.BMP-TAK1 (MAP3K7) Induces Adipocyte Differentiation Through PPARγ Signaling.Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.
P2860
Q21328702-C127DBC4-68B3-4561-A8D3-488564BBAF4BQ24314937-C06A5487-A40F-4010-8CF3-14B786AEFE5AQ24555727-6A8DA2A9-4A44-4437-BEAA-A07004997C45Q24564130-9C428DC6-B913-4FC9-BB0D-FD4271B082A8Q24806088-BF65E5FC-EC9E-4D34-A51E-CB89E182CBDBQ24815580-E587A11D-6013-463B-BE06-73C422AD3C42Q26739984-CE89BAB6-3D5F-4185-96F1-1E331987DD7EQ26746981-B305BF51-E0C6-4C88-96AE-41ABB29CE309Q26996783-B5073EF7-207B-45E5-8549-F84F9D5FAF93Q27311473-A90F2DDF-C9FA-4C59-A2DB-DD288F533590Q27322754-89F81ECB-2B80-495E-B114-79275805F9A2Q28354027-18DD527D-510B-4BEE-92C1-D02E37D26A1CQ28354293-27C67FA5-FF37-43F8-8A93-316BE1BDD9BCQ28468525-764219D3-BFED-4D8C-8C05-82BDC7A6E7DEQ28488272-38EC688F-B55E-4D72-8C9C-9584B59B1DF0Q28590733-0174A62C-17C5-4E18-A62C-8A7609DD103CQ28732013-44356491-0B4D-4C69-B1C5-317F6B26F46EQ29616709-BC8F5728-CAF7-43BB-845B-7269DA4C697BQ30241952-49B50D5B-15DD-45EE-921E-161B731721FCQ30395192-2E803907-ECAF-4816-803C-0349AFF55584Q33283063-B028EF0F-DFD9-447A-B528-C71246820534Q33372436-84D8E3F6-84DA-49CA-8DC2-DF360213C64EQ33388523-C2E2C61C-20A3-4898-910C-F0FC959F43E1Q33493427-339A1FA1-9DB9-4454-ADEB-EC4E310FAA98Q33558905-6457F75E-CB61-4023-8AE3-952DC038975EQ33582240-D3C28141-B637-44BE-A25E-9EC355789930Q33613991-507F3C8B-617B-4465-A450-2C3FB0F6CF9EQ33621757-F9AF2F36-FB6F-4BFA-9F4F-312D1F098C1CQ33634147-843ED863-F9FE-4DF5-BA63-441FE8DF60B2Q33662075-F1F95C7E-3F06-483F-A014-DA6523C39497Q33694606-E18B72FA-1005-484E-86B3-46BF6BC4E281Q33717836-8BF2EBCA-A3C4-4228-9D63-72A1F79A7957Q33727061-DC9B7639-E0B7-4556-B800-68EDEB80CD9AQ33736617-BFDEF778-333B-4D3B-90C6-EED55B89B910Q33796272-0111B027-BD4E-4F10-828E-41C6E2BB359DQ33838291-988A3974-0DD5-4BD0-A19C-498D7BCEFBA9Q33861769-919DF95C-6A58-444D-B87F-4C58583E91AFQ33907632-46AE96C1-AEA9-4096-91DC-AE134C3D73E4Q33917485-3061A1A9-DA8F-417A-B379-99F31ECFDEBDQ33922486-1482E6B5-81D6-4299-8EC2-5C344ADC602B
P2860
Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Liver peroxisome proliferator- ...... d regulation of body fat mass.
@en
Liver peroxisome proliferator- ...... d regulation of body fat mass.
@nl
type
label
Liver peroxisome proliferator- ...... d regulation of body fat mass.
@en
Liver peroxisome proliferator- ...... d regulation of body fat mass.
@nl
prefLabel
Liver peroxisome proliferator- ...... d regulation of body fat mass.
@en
Liver peroxisome proliferator- ...... d regulation of body fat mass.
@nl
P2093
P50
P356
P1476
Liver peroxisome proliferator- ...... nd regulation of body fat mass
@en
P2093
Charles Vinson
Christopher J Nicol
Frank J Gonzalez
Jaime J Cutson
Kimihiko Matsusue
Oksana Gavrilova
P304
34268-34276
P356
10.1074/JBC.M300043200
P407
P577
2003-06-11T00:00:00Z